Michael Hiltzik, Los Angeles Times; Column: COVID-19 could kill the for-profit science publishing model. That would be a good thing
"The current crisis has demonstrated the value of open access to research, as well as the drawbacks of secrecy."
Issues and developments related to ethics, information, and technologies, examined in the ethics and intellectual property graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology" will be published in Summer 2025. Kip Currier, PhD, JD
Showing posts with label coronaviruses. Show all posts
Showing posts with label coronaviruses. Show all posts
Thursday, March 5, 2020
Friday, February 7, 2020
Chinese scientists ask for patent on US drug to fight virus; Associated Press, February 6, 2020
Joe McDonald and Linda A. Johnson, Associated Press; Chinese scientists ask for patent on US drug to fight virus
"China has the right
under World Trade Organization rules to declare an emergency and compel a
company to license a patent to protect the public. It would be required
to pay a license fee that is deemed fair market value.
The
government might be able to avoid that fee if the patent were granted
to the Wuhan institute, part of the elite Chinese Academy of Sciences.
The
institute said it applied for a “use patent” that specifies the Wuhan
virus as the drug’s target. Gilead’s patent application, filed before
the virus was identified, cites only the overall family of
coronaviruses."
Subscribe to:
Posts (Atom)